25th Nov 2014 12:11
Annual General Meeting
LONDON - 25 November 2014 - Sinclair IS Pharma plc (AIM:SPH.L) ("the Company"), the international specialty pharmaceutical company, announces that at its Annual General Meeting held today all resolutions were duly passed. Full details of the proxy votes received for each resolution are now available in the investor relations area of the company's website at www.sinclairispharma.com.
For further information, please contact:
Sinclair IS Pharma plc | Tel: +44 (0) 20 7467 6920 |
Chris Spooner | |
Alan Olby | |
Peel Hunt LLP | Tel: +44 (0) 20 7418 8900 |
James Steel | |
Clare Terlouw |
Notes for editors:
About Sinclair IS Pharma plc - see www.sinclairispharma.com
Sinclair IS Pharma is an international specialty pharmaceutical company centred on Dermatology, in particular Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners.
Related Shares:
Sinclair Pharma